FDA Import Refusal SCS-3335259-3/11/1 — IBSA Farmaceutici Italia Srl
The FDA refused shipment SCS-3335259-3/11/1 from IBSA Farmaceutici Italia Srl (Italy) on Feb 22, 2019. The refused product falls under Drugs and Biologics — UROFOLLITROPIN (GONAD-STIMULATING PRINCIPLE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 22, 2019
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 64MCA10 UROFOLLITROPIN (GONAD-STIMULATING PRINCIPLE)
- Charges
- 75